menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Cutting Edge Technologies from Health 2.0

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Comments
  • Overview

    This week, Mark and Margaret speak with Indu Subaiya, Co-Chairman & CEO of Health 2.0, an annual leading showcase of the cutting-edge technologies transforming health and healthcare. Ms. Subaiya is responsible for Health 2.0's strategic direction and production values. She started her career in health technology assessment at Quorum Consulting and then served as VP of Healthcare at Gerson Lehrman Group, an investment research firm. When she is not running Health 2.0, she applies her producing and directing skills to making film. In 2013 Indu introduced us to the 7 Deadly Sins of Health Care and this year she will share what she has learned from her investigation into data sources that support a variety of health disparities across the United States.

     

Facebook Comments

Recommended
Details
Comments
  • Overview

    This week, Mark and Margaret speak with Indu Subaiya, Co-Chairman & CEO of Health 2.0, an annual leading showcase of the cutting-edge technologies transforming health and healthcare. Ms. Subaiya is responsible for Health 2.0's strategic direction and production values. She started her career in health technology assessment at Quorum Consulting and then served as VP of Healthcare at Gerson Lehrman Group, an investment research firm. When she is not running Health 2.0, she applies her producing and directing skills to making film. In 2013 Indu introduced us to the 7 Deadly Sins of Health Care and this year she will share what she has learned from her investigation into data sources that support a variety of health disparities across the United States.

     

Facebook Comments

Schedule19 Apr 2024